Suzhou Novoprotein Scientific Co. Ltd. A (688137.SS) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100005NZ4

Price
144.77 CNY
Market cap
10.16 bn CNY
P/E (2025)
–
P/S (2025)
69.38
Dividend yield
0.00 %
Net margin
-53.12 %
Return on equity (ROE)
-3.82 %
Return on assets (ROA)
-3.62 %

Suzhou Novoprotein Scientific Co. Ltd. A financials

Fiscal year20242025
Revenue127.56 m CNY146.44 m CNY
Gross profit79.57 m CNY98.29 m CNY
Operating income-55.40 m CNY-66.69 m CNY
EBIT-50.63 m CNY-67.83 m CNY
Net income-54.42 m CNY-77.78 m CNY
Diluted EPS – continuing operations-0.78 CNY-1.11 CNY

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Suzhou Novoprotein Scientific Co. Ltd. A

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technology solutions for biopharmaceuticals enterprises. The company offers mRNA vaccine drug raw materials, immunodiagnostic and molecular diagnostic raw materials, gene and cell therapy, molecular research reagents, cytokines, target proteins, cell lines, reference antibody, recombinant antibodies, enzymes and reagents, matrix gel and culture medium, and protein and virus research related products. It offers its products and services in the fields of biopharmaceuticals, mRNA vaccines and drugs, in vitro diagnostics, basic research of life sciences, and other areas. Novoprotein Scientific Inc. was founded in 2009 and is headquartered in Suzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.